$KALV
KalVista Pharmaceuticals, Inc.

2022 Q1 Form 10-Q Financial Statement

#000095017022003361 Filed on March 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.945M $6.057M $5.847M
YoY Change 95.08% 66.86% 78.26%
% of Gross Profit
Research & Development $19.74M $17.55M $13.67M
YoY Change 116.97% 91.8% 22.37%
% of Gross Profit
Depreciation & Amortization $149.0K $127.0K $132.0K
YoY Change 6.43% -2.31% 3.13%
% of Gross Profit
Operating Expenses $26.68M $23.60M $19.52M
YoY Change 110.82% 84.67% 35.15%
Operating Profit -$26.68M -$23.60M -$19.52M
YoY Change 110.82% 84.67%
Interest Expense $60.00K $10.00K $223.0K
YoY Change -86.36% -94.12% -68.14%
% of Operating Profit
Other Income/Expense, Net $4.216M $3.953M $3.184M
YoY Change 61.59% 67.86% 8.67%
Pretax Income -$22.47M -$19.65M -$16.11M
YoY Change 123.55% 88.4% 49.02%
Income Tax
% Of Pretax Income
Net Earnings -$22.47M -$19.65M -$16.11M
YoY Change 123.6% 88.47% 48.96%
Net Earnings / Revenue
Basic Earnings Per Share -$0.92 -$0.80 -$0.66
Diluted Earnings Per Share -$917.8K -$804.0K -$659.4K
COMMON SHARES
Basic Shares Outstanding 24.54M 24.47M 24.44M
Diluted Shares Outstanding 24.48M 24.44M 24.43M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $194.8M $209.8M $230.6M
YoY Change 287.17% 275.34% 258.68%
Cash & Equivalents $45.58M $46.49M $48.34M
Short-Term Investments $149.2M $163.3M $182.3M
Other Short-Term Assets $8.388M $7.266M $5.538M
YoY Change 82.35% 384.4% 67.82%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $214.5M $234.5M $249.8M
YoY Change 243.12% 225.21% 211.45%
LONG-TERM ASSETS
Property, Plant & Equipment $2.215M $2.180M $9.151M
YoY Change 18.58% -31.88% 161.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $193.0K $193.0K $200.0K
YoY Change -3.5% -3.5% 0.0%
Total Long-Term Assets $10.59M $9.332M $9.351M
YoY Change 186.47% 182.79% 152.59%
TOTAL ASSETS
Total Short-Term Assets $214.5M $234.5M $249.8M
Total Long-Term Assets $10.59M $9.332M $9.351M
Total Assets $225.1M $243.8M $259.1M
YoY Change 239.96% 223.36% 208.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.185M $3.159M $1.448M
YoY Change 264.17% 43.59% -19.56%
Accrued Expenses $6.450M $6.025M $5.876M
YoY Change 9.32% -18.58% -12.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.649M $10.11M $8.229M
YoY Change 48.04% 6.46% -3.19%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.467M $6.224M $6.474M
YoY Change 578.82% 591.56% 547.4%
Total Long-Term Liabilities $7.467M $6.224M $6.474M
YoY Change 564.92% 591.56% 547.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.649M $10.11M $8.229M
Total Long-Term Liabilities $7.467M $6.224M $6.474M
Total Liabilities $17.12M $16.34M $14.70M
YoY Change 124.0% 55.6% 54.77%
SHAREHOLDERS EQUITY
Retained Earnings -$226.1M -$203.6M -$183.9M
YoY Change 47.89%
Common Stock $436.3M $432.8M
YoY Change 105.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $207.9M $227.5M $244.4M
YoY Change
Total Liabilities & Shareholders Equity $225.1M $243.8M $259.1M
YoY Change 239.93% 223.36% 208.86%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income -$22.47M -$19.65M -$16.11M
YoY Change 123.6% 88.47% 48.96%
Depreciation, Depletion And Amortization $149.0K $127.0K $132.0K
YoY Change 6.43% -2.31% 3.13%
Cash From Operating Activities -$14.06M -$19.55M -$17.74M
YoY Change 85.31% 145.85% 394.29%
INVESTING ACTIVITIES
Capital Expenditures -$202.0K -$356.0K $287.0K
YoY Change 1920.0% 1680.0% 1204.55%
Acquisitions
YoY Change
Other Investing Activities $13.10M $18.00M $15.17M
YoY Change 88.28% 182.12% 173.79%
Cash From Investing Activities $12.90M $17.64M $14.88M
YoY Change 85.64% 176.97% 169.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 772.0K 63.00K 608.0K
YoY Change -54.59% 5.0% 1221.74%
NET CHANGE
Cash From Operating Activities -14.06M -19.55M -17.74M
Cash From Investing Activities 12.90M 17.64M 14.88M
Cash From Financing Activities 772.0K 63.00K 608.0K
Net Change In Cash -391.0K -1.839M -2.249M
YoY Change -136.89% 20.99% -201.08%
FREE CASH FLOW
Cash From Operating Activities -$14.06M -$19.55M -$17.74M
Capital Expenditures -$202.0K -$356.0K $287.0K
Free Cash Flow -$13.86M -$19.19M -$18.02M
YoY Change 82.89% 141.98% 399.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001348911
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-01-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36830
dei Entity Registrant Name
EntityRegistrantName
KALVISTA PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0915291
dei Entity Address Address Line1
EntityAddressAddressLine1
55 Cambridge Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 901E
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
dei City Area Code
CityAreaCode
857
dei Local Phone Number
LocalPhoneNumber
999-0075
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
KALV
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7467000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2185000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1981000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6450000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6930000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1014000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
863000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9649000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9774000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7467000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5046000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24543256
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45577000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50592000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
149212000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
198337000
CY2022Q1 kalv Research And Development Tax Credits Receivable
ResearchAndDevelopmentTaxCreditsReceivable
11287000
CY2021Q2 kalv Research And Development Tax Credits Receivable
ResearchAndDevelopmentTaxCreditsReceivable
10418000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8388000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4917000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
214464000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
264264000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2215000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1791000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8180000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5758000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
193000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
200000
CY2022Q1 us-gaap Assets
Assets
225052000
CY2021Q2 us-gaap Assets
Assets
272013000
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5046000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24537094
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24537094
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24422531
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24422531
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
24000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
24000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
436313000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
426437000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226062000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-167836000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2339000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1432000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
207936000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
257193000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
225052000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
272013000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19738000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9097000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50954000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29409000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6945000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3560000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18848000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10472000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
26683000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
12657000
us-gaap Operating Expenses
OperatingExpenses
69802000
us-gaap Operating Expenses
OperatingExpenses
39881000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-26683000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12657000
us-gaap Operating Income Loss
OperatingIncomeLoss
-69802000
us-gaap Operating Income Loss
OperatingIncomeLoss
-39881000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
258000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
137000
us-gaap Investment Income Interest
InvestmentIncomeInterest
822000
us-gaap Investment Income Interest
InvestmentIncomeInterest
589000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-198000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
301000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-529000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
715000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4156000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2171000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11283000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7289000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4216000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2609000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11576000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8593000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22467000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-10048000
us-gaap Net Income Loss
NetIncomeLoss
-58226000
us-gaap Net Income Loss
NetIncomeLoss
-31288000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-445000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
813000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-430000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1024000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-350000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-48000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-773000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-217000
CY2022Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-176000
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
76000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-296000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
192000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-619000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
689000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-907000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
615000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23086000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9359000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59133000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30673000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.92
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.56
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.38
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.75
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24479660
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17961802
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24449788
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17905926
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
257193000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
608000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2795000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-16109000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
49000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-129000
CY2021Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-23000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
244430000
CY2021Q4 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
63000
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2860000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-19650000
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000
CY2021Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-295000
CY2021Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-97000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
227472000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
773000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2777000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22467000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-445000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-350000
CY2022Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-176000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
207936000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
83752000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1188000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-10814000
CY2020Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
46000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
338000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000
CY2020Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
70000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
74435000
CY2020Q4 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
60000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1248000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-10426000
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-127000
CY2020Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-164000
CY2020Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
46000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
64980000
CY2021Q1 kalv Stockissuancecosts
Stockissuancecosts
132000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1648000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
55000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1241000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-10048000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
813000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
813000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-48000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-48000
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
76000
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
76000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
58565000
us-gaap Profit Loss
ProfitLoss
-58226000
us-gaap Profit Loss
ProfitLoss
-31288000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
408000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
397000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8432000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3677000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-296000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
192000
kalv Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
153000
kalv Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
25000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2081000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
247000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-698000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
441000
kalv Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
1477000
kalv Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
-10135000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3659000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-35000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
228000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1182000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-279000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-539000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51345000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19126000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
84415000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
26814000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
130686000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
45692000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
845000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
45426000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18829000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1648000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1443000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
161000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1443000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1809000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-539000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
426000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5015000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1938000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50592000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15789000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
45577000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17727000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3185000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
19000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226100000
CY2022Q1 kalv Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
194800000
CY2022Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
12094000
CY2022Q1 kalv Cash And Cash Equivalents And Marketable Securities Fair Value Disclosure
CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
161306000
CY2021Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2985000
CY2021Q2 kalv Cash And Cash Equivalents And Marketable Securities Fair Value Disclosure
CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
201322000
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
149889000
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
680000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
149212000
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
198536000
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
62000
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
261000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
198337000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
109859000
CY2022Q1 kalv Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
23931000
CY2022Q1 kalv Available For Sale Securities Debt Maturities After Two Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughFiveYearsFairValue
15422000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
149212000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3252000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3507000
CY2022Q1 kalv Accrued Research Expense Current
AccruedResearchExpenseCurrent
2415000
CY2021Q2 kalv Accrued Research Expense Current
AccruedResearchExpenseCurrent
2476000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
596000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
557000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
187000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
390000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6450000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6930000
CY2022Q1 kalv Contractual Obligation Remaining Commitment Including Cancellation Provisions
ContractualObligationRemainingCommitmentIncludingCancellationProvisions
35700000
kalv Amount Associated With Indemnification
AmountAssociatedWithIndemnification
0
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
435000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1631000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1511000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1547000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1585000
CY2022Q1 kalv Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
4721000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11430000
CY2022Q1 kalv Lessee Operating Lease Liability Minimum Payments Interest Included In Payments
LesseeOperatingLeaseLiabilityMinimumPaymentsInterestIncludedInPayments
2949000
CY2022Q1 kalv Lessee Operating Lease Liability Present Value Of Net Minimum Payments
LesseeOperatingLeaseLiabilityPresentValueOfNetMinimumPayments
8481000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1014000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7467000

Files In Submission

Name View Source Status
0000950170-22-003361-index-headers.html Edgar Link pending
0000950170-22-003361-index.html Edgar Link pending
0000950170-22-003361.txt Edgar Link pending
0000950170-22-003361-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kalv-20220131.htm Edgar Link pending
kalv-20220131.xsd Edgar Link pending
kalv-20220131_cal.xml Edgar Link unprocessable
kalv-20220131_def.xml Edgar Link unprocessable
kalv-20220131_htm.xml Edgar Link completed
kalv-20220131_lab.xml Edgar Link unprocessable
kalv-20220131_pre.xml Edgar Link unprocessable
kalv-ex31_1.htm Edgar Link pending
kalv-ex31_2.htm Edgar Link pending
kalv-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending